No abstract

Almost all countries are facing obesity endemic, although great variation exists between and within countries. Sedentary lifestyle and high fat (high caloric) diet have increased globally as a result of industrial, urban and mechanic changes of developing countries. Improved economic status promotes the obesity and metabolic syndrome in all age groups particularly young adults. Developing counties became in desperate need for establishing new polices and strategies within regulated and managed programs; in order to encounter factors of highly spread malnutrition displayed by obesity and its consequences like diabetes, CVD and metabolic syndrome. Developed and developing countries have studied the obesity prevalence, showing important statistics as the obesity hugely escalated in all population groups. Obesity and its related non-communicable diseases (NCDs) have new pandemic facts that force the World Health Organization (WHO) to deal with.WHO noticed that obesity and NCDs will affect majorly the developing countries, and the expected numbers of new cases within the next 2 decades will exceed hundreds of millions. This review, discusses the epidemiology of obesity, lifestyle and nutritional transitions, determinants, social and economic impacts, and possible solutions for prevention of obesity in developing countries.

Inflammation is the main key role in developing chronic diseases including cancer, cardiovascular diseases, diabetes, arthritis, and neurodegenerative diseases which possess a huge challenge for treatment. With massively compelling evidence of the role played by nutritional modulation in preventing inflammation-related diseases, there is a growing interest into the search for natural functional foods with therapeutic and preventive actions. Honey, a nutritional healthy product, is produced mainly by two types of bees: honeybee and stingless bee. Since both types of honey possess distinctive phenolic and flavonoid compounds, there is recently an intensive interest in their biological and clinical actions against inflammation-mediated chronic diseases. This review shed the light specifically on the bioavailability and bioaccessibility of honey polyphenols and highlight their roles in targeting inflammatory pathways in gastrointestinal tract disorders, edema, cancer, metabolic and cardiovascular diseases and gut microbiota.

Background Epidemiological and experimental studies have extensively indicated that chronic subclinical systemic inflammation (CSSI) and oxidative stress are risk factors for several chronic diseases, including cancer, arthritis, type 2 diabetes, and cardiovascular and neurodegenerative diseases. This study examined the protective effect of stingless bee honey (SBH) supplementation against lipopolysaccharide (LPS)-induced CSSI, pointing to the possible involvement of NF-κB, p38 MAPK and Nrf2 signaling. Methods CSSI was induced in male Sprague Dawley rats by intraperitoneal injection of LPS three times per week for 28 days, and SBH (4.6 and 9.3 g/kg/day) was supplemented for 30 days. Results LPS-induced rats showed significant leukocytosis, and elevated serum levels of CRP, TNF-α, IL-1β, IL-6, IL-8, MCP-1, malondialdehyde (MDA) and 8-hydroxy-2′-deoxyguanosine (8-OHdG), accompanied with diminished antioxidants. Treatment with SBH significantly ameliorated inflammatory markers, MDA and 8-OHdG, and enhanced antioxidants in LPS-induced rats. In addition, SBH decreased NF-κB p65 and p38 MAPK, and increased Nrf2 expression in the liver, kidney, heart and lung of LPS-induced rats. Furthermore, SBH prevented LPS-induced histological and functional alterations in the liver, kidney, heart and lung of rats. Conclusion SBH has a substantial protective role against LPS-induced CSSI in rats mediated via amelioration of inflammation, oxidative stress and NF-κB, p38 MAPK and Nrf2 signaling.

No abstract